Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1990 1
1994 1
1996 2
1998 2
1999 1
2000 4
2002 1
2004 3
2006 1
2009 2
2010 1
2011 2
2012 2
2013 1
2016 2
2017 3
2018 3
2019 2
2020 2
2021 2
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Among authors: aspinall rj. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.
McPherson S, Armstrong MJ, Cobbold JF, Corless L, Anstee QM, Aspinall RJ, Barclay ST, Brennan PN, Cacciottolo TM, Goldin RD, Hallsworth K, Hebditch V, Jack K, Jarvis H, Johnson J, Li W, Mansour D, McCallum M, Mukhopadhya A, Parker R, Ross V, Rowe IA, Srivastava A, Thiagarajan P, Thompson AI, Tomlinson J, Tsochatzis EA, Yeoman A, Alazawi W. McPherson S, et al. Among authors: aspinall rj. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):755-769. doi: 10.1016/S2468-1253(22)00061-9. Epub 2022 Apr 28. Lancet Gastroenterol Hepatol. 2022. PMID: 35490698 Free PMC article. Review.
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.
Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D. Tripathi D, et al. Among authors: aspinall rj. Gut. 2020 Jul;69(7):1173-1192. doi: 10.1136/gutjnl-2019-320221. Epub 2020 Feb 29. Gut. 2020. PMID: 32114503 Free PMC article.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DEJ, Dörffel Y, Gordon SC, Harrison SA, Kremer AE, Mayo MJ, Thuluvath PJ, Levy C, Swain MG, Neff GW, Sheridan DA, Stanca CM, Berg CP, Goel A, Shiffman ML, Vierling JM, Boudes P, Steinberg A, Choi YJ, McWherter CA. Bowlus CL, et al. Among authors: aspinall rj. J Hepatol. 2022 Aug;77(2):353-364. doi: 10.1016/j.jhep.2022.02.033. Epub 2022 Mar 30. J Hepatol. 2022. PMID: 35367282 Free article. Clinical Trial.
Liver fibrosis for the dermatologist: a review.
Raahimi MM, Livesey A, Hamilton J, Shipman AR, Aspinall RJ. Raahimi MM, et al. Among authors: aspinall rj. Clin Exp Dermatol. 2023 Mar 22;48(4):303-309. doi: 10.1093/ced/llac083. Clin Exp Dermatol. 2023. PMID: 36763770 Review.
SCV-07 (SciClone Pharmaceuticals/Verta).
Aspinall RJ, Pockros PJ. Aspinall RJ, et al. Curr Opin Investig Drugs. 2006 Feb;7(2):180-5. Curr Opin Investig Drugs. 2006. PMID: 16499289 Review.
50 results